Please assess the completion status of the following clinical trial:

Trial Title: A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer in the Treatment of Patients With Stable COPD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients ≥ 40 years of age.~2. Diagnosis of COPD.~3. Currently using only a mouthpiece with their nebulizer system.~4. Forced Expiratory Volume at 1 second (FEV1) ≥ 30% predicted (pre or post bronchodilator).~5. Modified Medical Research Council (mMRC) Dyspnea scale grade ≥ 1.~6. Use of a jet nebulizer for the administration of albuterol or combination albuterol/ipratropium for the past 6 months~7. Willing to use the same compressor/nebulizer system throughout the study~8. Willing to refrain from using the jet nebulizer system when using InnoSpire Go~9. Prescribed nebulizer combination albuterol/ipratropium (single or multiple vials) with self-report of at least daily use or prescribed nebulizer albuterol with self-report of at least twice daily use.~10. Willing to permit audio and video recording during the visit.~11. Willing and able to follow instructions and complete all activities required by the trial, including phone calls.~12. Able to read and understand English.~Exclusion Criteria:~1. Unable to complete 6MWT or, if patient is not currently prescribed oxygen, persistent oxygen desaturation ≤ 88% on the 6MWT.~2. Exacerbation of COPD requiring hospitalization in the last 3 months (defined as hospital admission, urgent care visit, or emergency room visit).~3. Prescribed non-selective beta blockers.~4. Prescribed additional ipratropium bromide via nebulizer or inhaler or any other nebulized treatments via the subject's jet nebulizer.~5. Patients currently in assisted living or nursing home.~6. Diagnosis of asthma, parenchymal lung disease other than COPD, bronchiectasis, tuberculosis, cor pulmonale, clinically significant obstructive urinary disease, narrow-angle glaucoma, unstable angina, depression, anxiety, or other serious medical condition that, in the opinion of the investigator, would interfere with the patient's participation in the trial.~7. History of thoracotomy.~8. Myocardial infarction within the last 6 months.~9. Participation in any other therapeutic clinical trial in the previous 4 weeks

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- InnoSpire Go (Type: EXPERIMENTAL): The InnoSpire Go is a handheld, single patient use, vibrating mesh nebulizer system designed to aerosolize liquid medications for respiratory disease. The device operates continuously once initiated and automatically switches off once the medication has been delivered. The device may be used in pediatric and adult populations, as permitted by the prescribed medication, and is suitable for use in home environments or hospital/clinic settings.
- Jet Nebulizer (Type: ACTIVE_COMPARATOR): Jet Nebulizers are the standard delivery system for aerosolized medications. A nebulizer breaks up medical solutions into small droplets suspended in air (aerosol) so that they may be delivered to the patient's airways for respiratory therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete